TABLE OF CONTENT: 1. Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. Key Insights 4.1. Prevalence of vitiligo by key countries 4.2. Pipeline analysis 4.3. Recent industry developments - mergers & acquisitions 4.4. Recent developments in R&D 5. Global Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026 5.1. Key Findings / Summary 5.2. Market Analysis, Insights and Forecast – By Treatment 5.2.1. Topical Treatment 5.2.2. Light Therapy 5.2.3. Surgical Procedures 5.2.4. Others 5.3. Market Analysis, Insights and Forecast – By Disease Type 5.3.1. Nonsegmental Vitiligo 5.3.2. Segmental Vitiligo 5.4. Market Analysis, Insights and Forecast – By End-user 5.4.1. Hospitals 5.4.2. Aesthetic Clinics 5.4.3. Others 5.5. Market Analysis, Insights and Forecast – By Region 5.5.1. North America 5.5.2. Europe 5.5.3. Asia pacific 5.5.4. Latin America 5.5.5. Middle East & Africa 6. North America Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026 6.1. Key Findings / Summary 6.2. Market Analysis – By Treatment 6.2.1. Topical Treatment 6.2.2. Light Therapy 6.2.3. Surgical Procedures 6.2.4. Others 6.3. Market Analysis – By Disease Type 6.3.1. Nonsegmental Vitiligo 6.3.2. Segmental Vitiligo 6.4. Market Analysis – By End-user 6.4.1. Hospitals 6.4.2. Aesthetic Clinics 6.4.3. Others 6.5. Market Analysis – By Country 6.5.1. U.S. 6.5.2. Canada 7. Europe Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026 7.1. Key Findings / Summary 7.2. Market Analysis – By Treatment 7.2.1. Topical Treatment 7.2.2. Light Therapy 7.2.3. Surgical Procedures 7.2.4. Others 7.3. Market Analysis – By Disease Type 7.3.1. Nonsegmental Vitiligo 7.3.2. Segmental Vitiligo 7.4. Market Analysis – By End-user 7.4.1. Hospitals 7.4.2. Aesthetic Clinics 7.4.3. Others 7.5. Market Analysis – By Country/Sub-region 7.5.1. U.K. 7.5.2. Germany 7.5.3. France 7.5.4. Spain 7.5.5. Italy 7.5.6. Scandinavia 7.5.7. Rest of Europe 8. Asia pacific Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026 8.1. Key Findings / Summary 8.2. Market Analysis – By Treatment 8.2.1. Topical Treatment 8.2.2. Light Therapy 8.2.3. Surgical Procedures 8.2.4. Others 8.3. Market Analysis – By Disease Type 8.3.1. Nonsegmental Vitiligo 8.3.2. Segmental Vitiligo 8.4. Market Analysis – By End-user 8.4.1. Hospitals 8.4.2. Aesthetic Clinics 8.4.3. Others 8.5. Market Analysis – By Country/Sub-region 8.5.1. Japan 8.5.2. China 8.5.3. India 8.5.4. Australia 8.5.5. Southeast Asia 8.5.6. Rest of Asia Pacific 9. Latin America Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026 9.1. Key Findings / Summary 9.2. Market Analysis – By Treatment 9.2.1. Topical Treatment 9.2.2. Light Therapy 9.2.3. Surgical Procedures 9.2.4. Others 9.3. Market Analysis – By Disease Type 9.3.1. Nonsegmental Vitiligo 9.3.2. Segmental Vitiligo 9.4. Market Analysis – By End-user 9.4.1. Hospitals 9.4.2. Aesthetic Clinics 9.4.3. Others 9.5. Market Analysis – By Country/Sub-region 9.5.1. Brazil 9.5.2. Mexico 9.5.3. Rest of Latin America 10. Middle East & Africa Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026 10.1. Key Findings / Summary 10.2. Market Analysis – By Treatment 10.2.1. Topical Treatment 10.2.2. Light Therapy 10.2.3. Surgical Procedures 10.2.4. Others 10.3. Market Analysis – By Disease Type 10.3.1. Nonsegmental Vitiligo 10.3.2. Segmental Vitiligo 10.4. Market Analysis – By End-user 10.4.1. Hospitals 10.4.2. Aesthetic Clinics 10.4.3. Others 10.5. Market Analysis – By Country/Sub-region 10.5.1. GCC Countries 10.5.2. South Africa 10.5.3. Rest of Middle East & Africa 11. Competitive Analysis 11.1. Key Industry Developments 11.2. Global Market Share Analysis (2018) 11.3. Competition Dashboard 11.4. Comparative Analysis – Major Players 11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability)) 11.5.1. Incyte Corporation 11.5.2. Astellas Pharma Inc. 11.5.3. Bausch Health Companies Inc. 11.5.4. Baxter International Inc. 11.5.5. Dr. Reddy’s Laboratories Ltd. 11.5.6. Pfizer Inc. 11.5.7. STRATA Skin Sciences 12. Strategic Recommendation

Incyte Corporation Astellas Pharma Inc. Bausch Health Companies Inc. Baxter International Inc. Pfizer Inc. STRATA Skin Sciences Reddy’s Laboratories Ltd. Other players